Serum Institute to price Covid-19 vaccine at $3 per dose for India and lower middle income nations

As part of the agreement SII will also get upfront capital of $150 mn via the Bill and Melinda Gates Foundation to help the company increase manufacturing capacity now so that, once a vaccine, or vaccines, gains regulatory approval and WHO prequalification, doses can be produced at scale for distribution under the COVAX agreement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/31rWGUf
via IFTTT